Pedometers for Gestational Diabetes
- Conditions
- Gestational Diabetes
- Interventions
- Behavioral: Stepping Up to Health
- Registration Number
- NCT00862602
- Lead Sponsor
- University of Michigan
- Brief Summary
Ten to 50% of women with gestational diabetes (GDM), or glucose intolerance first recognized during pregnancy, develop diabetes within 5 years after delivery. Although intensive interventions can reduce diabetes incidence in women with impaired glucose tolerance, it is unknown if such strategies would be effective in women with GDM. Women with recent GDM, even though no longer pregnant, face significant barriers to lifestyle modification, including caregiving responsibilities and low perception of risk. Web-based programs can reinforce physical activity through visual feedback of pedometer output, tailored messaging, education, and on-line communities. Such a program is currently available for adults with chronic disease and is led by Dr. Richardson, a co-PI on this application. Using data from focus group and survey work conducted by Dr. Kim, the other co-PI, this program can be modified to women with recent GDM. For Specific Aim 1, we propose to adapt a chronic disease web-based pedometer program to women with recent GDM. For Specific Aim 2, we propose to conduct a pilot and feasibility study of the program. The intervention will last 12 weeks.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 60
- Gestational diabetes diagnosis within past three years
- Access to computer with internet, USB port and Windows XP or Vista
- Regular email user (weekly or more)
- Can walk a block on her own
- Sedentary (less than 150 minutes purposeful physical activity per week)
- Pregnancy
- Unable to consent legally
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description 1 Stepping Up to Health Stepping Up to Health
- Primary Outcome Measures
Name Time Method Weight loss Pre-post Glucose tolerance Pre-Post
- Secondary Outcome Measures
Name Time Method Hemoglobin A1c Pre-post Step counts Pre-Post Insulin Pre-post
Trial Locations
- Locations (1)
University of Michigan Health System
🇺🇸Ann Arbor, Michigan, United States